Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Patent Expiration	Exclusivity Expiration
Merck	SINGULAIR	montelukast sodium	020829	Feb 20, 1998	RX	Yes			AUG 20,2003
Merck	SINGULAIR	montelukast sodium	020829	Feb 20, 1998	RX	Yes			DEC 31,2005
Merck	SINGULAIR	montelukast sodium	020829	Feb 20, 1998	RX	Yes	5,565,473*PED	AUG 03,2012

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: SINGULAIR

Drugname	Dosage	Strength	RLD	Submissiondate
montelukast	Tablets	10 mg	Singulair	2/20/2007
montelukast sodium	Chewable Tablets	4 mg and 5 mg	Singulair	12/26/2006

<- Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...